Conditions: Central Nervous System Diseases
Keywords: disease of the central nervous system (brain or spine)
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 92
Healthy volunteers: no

Brief summary:
The purpose of this study was to assess the safety and enhancing properties of the magnetic resonance imaging (MRI) contrast agent MultiHance in children aged 2 to 17 years having central nervous system (CNS) disorders.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: gadobenate dimeglumine
Intervention descriptions: intervention 1: A dose of 0.10 mmol/kg (i.e., 0.2 mL/kg) of 0.5 molar MultiHance was injected intravenously at a rate of 2 mL/sec as a single dose.

Protocol document: